Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 3Phase 2 3Phase 1/2 3Phase 1 3Phase NA 1

Status

Active not recruiting 4Unknown 3Recruiting 3Terminated 1Not yet recruiting 1Enrolling by invitation 1Completed 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Carcinoma, Non-Small-Cell Lung 72Breast Neoplasms 63Neoplasms 59Leukemia, Myeloid, Acute 58Multiple Myeloma 52Colorectal Neoplasms 48Lymphoma 46Stomach Neoplasms 43Recurrence 43Carcinoma, Hepatocellular 43Pancreatic Neoplasms 40Neoplasm Metastasis 39Melanoma 34Prostatic Neoplasms 33Leukemia 30Lymphoma, Non-Hodgkin 27Lymphoma, B-Cell 27Lung Neoplasms 27Precursor Cell Lymphoblastic Leukemia-Lymphoma 24Glioblastoma 24Ovarian Neoplasms 23Lymphoma, Large B-Cell, Diffuse 21Esophageal Neoplasms 21Carcinoma, Renal Cell 20Myelodysplastic Syndromes 19Leukemia, Lymphocytic, Chronic, B-Cell 19Hematologic Neoplasms 19Colonic Neoplasms 19Head and Neck Neoplasms 18Lymphoma, Mantle-Cell 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × Unknown × Metastatic Castration-resistant Prostate Cancer × Clear all
NCT06250244 2024-12-11

177Lu-LNC1011 in Patients with Metastatic Castration-resistant Prostate Cancer

Peking Union Medical College Hospital

Phase 1/2 Unknown
12 enrolled
Genitourinary

Metastatic Castration-resistant Prostate Cancer

NCT05458544 2024-04-29

LUCIDA

FutureChem

Phase 1/2 Unknown
26 enrolled
Genitourinary

Metastatic Castration-resistant Prostate Cancer

NCT03085966 2017-03-21

Autologous Immune Cell Therapy in Combination With LHRH-a in Patients With mCRPC

Shanghai AbelZeta Ltd.

Phase 1/2 Unknown
30 enrolled
Genitourinary

Metastatic Castration-resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡